Oral Session 1-7B Malignant Lymphoma: Clinical Trials and Observation Studies

[OS1-7B-4] Long-term outcomes and diagnosis-to-treatment interval (DTI) in NK/T-cell lymphoma: NKEA study

Motoko Yamaguchi¹, Ritsuro Suzuki², Masahiko Oguchi³, Kana Miyazaki¹, Senzo Taguchi³, Jun Amaki⁴, Takeshi Maeda⁵, Nobuko Kubota⁶, Dai Maruyama⁷, Yasuhito Terui³, Nodoka Sekiguchi⁸, Jun Takizawa⁹, Hiroyuki Tsukamoto¹⁰, Tohru Murayama¹¹, Toshihiko Ando¹², Hiroshi Matsuoka¹³, Masatoshi Hasegawa¹⁴, Hideho Wada¹⁵, Rika Sakai¹⁶, Yoshihiro Kameoka¹⁷, Norifumi Tsukamoto¹⁸, Ilseung Choi¹⁹, Yasufumi Masaki²⁰, Kazuyuki Shimada²¹, Noriko Fukuhara²², Takahiko Utsumi²³, Nobuhiko Uoshima²⁴, Yoshitoyo Kagami²⁵, Naoko Asano²⁶, Naoyuki Katayama¹ (1.Mie Univ. Grad. Sch. of Med., Tsu, Japan, 2.Shimane Univ. Hosp., Izumo, Japan, 3.Cancer Institute Hosp. of JFCR, Tokyo, Japan, 4.Tokai Univ., Kanagawa, Japan, 5.Kurashiki Central Hosp., Kurashiki, Japan, 6.Saitama Cancer Ctr., Ina, Japan, 7.National Cancer Ctr. Hosp., Tokyo, Japan, 8.Shinshu Univ., Matsumoto, Japan, 9.Niigata Univ., Niigata, Japan, 10.Showa Univ., Tokyo, Japan, 11.Hyogo Cancer Ctr., Akashi, Japan, 12.Saga Univ., Saga, Japan, 13.Kobe Univ., Kobe, Japan, 14.Nara Med. Univ., Kashihara, Japan, 15.Kawasaki Med. Sch., Kurashiki, Japan, 16.Kanagawa Cancer Ctr., Yokohama, Japan, 17.Akita Univ., Akita, Japan, 18.Gunma Univ. Hosp., Maebashi, Japan, 19.NHO Kyushu Cancer Ctr., Fukuoka, Japan, 20.Kanazawa Med. Univ., Ishikawa, Japan, 21.Nagoya Univ., Nagoya, Japan, 22.Tohoku Univ., Sendai, Japan, 23.Shiga Med. Ctr. for Adults, Moriyama, Japan, 24.Japanese Red Cross Kyoto Daini Hosp., Kyoto, Japan, 25.Toyota Kosei Hosp., Toyota, Japan, 26.Shinshu Med. Ctr., Suzaka, Japan)